Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Geron (GERN) over the last 5 years, with Sep 2025 value amounting to $667.1 million.

  • Geron's Shares Outstanding (Diluted Average) rose 0.75% to $667.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $667.1 million, marking a year-over-year increase of 0.75%. This contributed to the annual value of $646.0 million for FY2024, which is 13.21% up from last year.
  • According to the latest figures from Q3 2025, Geron's Shares Outstanding (Diluted Average) is $667.1 million, which was up 0.14% from $666.2 million recorded in Q2 2025.
  • In the past 5 years, Geron's Shares Outstanding (Diluted Average) registered a high of $667.1 million during Q3 2025, and its lowest value of $327.0 million during Q2 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $646.0 million (2024), whereas its average is $619.4 million.
  • Data for Geron's Shares Outstanding (Diluted Average) shows a peak YoY soared of 63.96% (in 2023) over the last 5 years.
  • Over the past 5 years, Geron's Shares Outstanding (Diluted Average) (Quarterly) stood at $327.6 million in 2021, then rose by 16.22% to $380.8 million in 2022, then skyrocketed by 49.86% to $570.6 million in 2023, then rose by 13.21% to $646.0 million in 2024, then rose by 0.75% to $667.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $667.1 million for Q3 2025, versus $666.2 million for Q2 2025 and $665.9 million for Q1 2025.